Intra-Cellular Therapies ... (ITCI)

ITCI trades at $131.87, 46.5% above the near-term max pain of $90 expiring Nov 21, 2025 (47 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($7-$90), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ITCI shows a downward trend from 90 to 7, indicating bearish sentiment or hedging activity. The 185% spread signals divergent expectations across timeframes. Most levels below 131.87 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.